help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, H.
Right arrow Articles by Busse, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, H.
Right arrow Articles by Busse, W. W.

Am. J. Respir. Cell Mol. Biol., Volume 23, Number 3, September, 2000 379-388

The Effect of Transendothelial Migration on Eosinophil Function

Hideaki Yamamoto, Julie B. Sedgwick, Rose F. Vrtis, and William W. Busse

Pulmonary Division, Second Department of Internal Medicine, Saitama Medical School, Saitama, Japan; and Section of Allergy and Clinical Immunology, Department of Medicine, University of Wisconsin, Madison, Wisconsin

In bronchial asthma, eosinophils found in the airways have an enhanced inflammatory capacity. We hypothesized that, at least in part, changes in functional phenotype are due to the effect of transendothelial migration. To model in vivo eosinophil trafficking to the lung, we cultured human pulmonary microvascular endothelial cell (HPMEC) monolayers on Transwell filters. The HPMECs were activated with interleukin (IL)-1beta to increase cell expression of intercellular adhesion molecule (ICAM)-1 and, hence, eosinophil transmigration. Peripheral blood eosinophils from allergic patients were added to HPMEC-covered Transwell filters and incubated for 3 h at 37°C. The eosinophils were collected from below (migrated cells) and above (nonmigrated cells) the HPMEC monolayer to determine surface receptor expression, in vitro survival, and oxidative burst. Eosinophils never exposed to HPMECs were used as controls. Eosinophil cell surface expression of CD69, human leukocyte-associated antigen-DR (HLA-DR), and CD54 (ICAM-1) was significantly increased after transendothelial migration through IL-1beta -treated HPMECs compared with control cells (CD69: P < 0.0005; HLA-DR and CD54: P < 0.05) and nonmigrated eosinophils (CD69 and HLA-DR: P < 0.05). Moreover, the percent in vitro survival (48 h) of migrated eosinophils was also significantly greater (P < 0.0001 by trypan blue exclusion, P < 0.05 by flow cytometry) than that of control or nonmigrated eosinophils. Prolonged survival of migrated eosinophils was inhibited by addition of anti-granulocyte macrophage colony-stimulating factor (GM-CSF) antibodies (P < 0.05) to the 48-h survival culture, suggesting that autocrine production of GM-CSF was, at least partially, responsible for increased eosinophil survival. Although GM-CSF protein was not measurable in survival culture supernates, GM-CSF messenger RNA (mRNA) was expressed in both nonmigrated and migrated eosinophils but not in control cells. Similarly, the eosinophils' oxidative burst induced by platelet-activating factor, formylmethionyl leucylphenylalanine, or phorbol myristate acetate was equally, and significantly, increased in both nonmigrated and migrated eosinophils (P < 0.05 versus control). Therefore, whereas exposure of eosinophils to cytokine-activated HPMECs can increase surface receptor expression, in vitro survival, GM-CSF mRNA, and the respiratory burst, transendothelial migration can further potentiate receptor expression and survival in migrated cells. These results suggest that the process of transendothelial migration selectively participates in determining the eventual phenotype of airway eosinophils.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H.-B. Wang, I. Ghiran, K. Matthaei, and P. F. Weller
Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells
J. Immunol., December 1, 2007; 179(11): 7585 - 7592.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Farahi, A. S. Cowburn, P. D. Upton, J. Deighton, A. Sobolewski, E. Gherardi, N. W. Morrell, and E. R. Chilvers
Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells
J. Immunol., July 15, 2007; 179(2): 1264 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. A. Lokuta and A. Huttenlocher
TNF-{alpha} promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway
J. Leukoc. Biol., July 1, 2005; 78(1): 210 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-Z. Shi
Eosinophils function as antigen-presenting cells
J. Leukoc. Biol., September 1, 2004; 76(3): 520 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. J. Bolton, C. A. McNulty, R. J. Thomas, C. R. A. Hewitt, and A. J. Wardlaw
Expression of and functional responses to protease-activated receptors on human eosinophils
J. Leukoc. Biol., July 1, 2003; 74(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M-J. Dallaire, C. Ferland, N. Page, S. Lavigne, F. Davoine, and M. Laviolette
Endothelial cells modulate eosinophil surface markers and mediator release
Eur. Respir. J., June 1, 2003; 21(6): 918 - 924.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. Liu, L. Hakansson, P. Ridefelt, R. C. Garcia, and P. Venge
Priming of Eosinophil Migration Across Lung Epithelial Cell Monolayers and Upregulation of CD11b/CD18 Are Elicited by Extracellular Ca2+
Am. J. Respir. Cell Mol. Biol., June 1, 2003; 28(6): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Holub, J. Byrnes, S. Anderson, L. Dzaidzio, N. Hogg, and A. Huttenlocher
Ligand density modulates eosinophil signaling and migration
J. Leukoc. Biol., May 1, 2003; 73(5): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Lokuta, P. A. Nuzzi, and A. Huttenlocher
Calpain regulates neutrophil chemotaxis
PNAS, April 1, 2003; 100(7): 4006 - 4011.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Gardai, R. Hoontrakoon, C. D. Goddard, B. J. Day, L. Y. Chang, P. M. Henson, and D. L. Bratton
Oxidant-Mediated Mitochondrial Injury in Eosinophil Apoptosis: Enhancement by Glucocorticoids and Inhibition by Granulocyte-Macrophage Colony-Stimulating Factor
J. Immunol., January 1, 2003; 170(1): 556 - 566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Burg, V. Krump-Konvalinkova, F. Bittinger, and C. J. Kirkpatrick
GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L460 - L467.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Levi-Schaffer, A. Micera, E. Zamir, H. Mechoulam, I. Puxeddu, A. M. Piliponsky, L. Aloe, and J. Pe'er
Nerve Growth Factor and Eosinophils in Inflamed Juvenile Conjunctival Nevus
Invest. Ophthalmol. Vis. Sci., June 1, 2002; 43(6): 1850 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. G. Zangrilli
Regulation of Eosinophil Viability by Cytokines
Am. J. Respir. Cell Mol. Biol., April 1, 2002; 26(4): 388 - 390.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2000 American Thoracic Society.